AIMMUNE THERAPEUTICS, INC.
Share on:
| Name: | AIMMUNE THERAPEUTICS, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 15 May 2019 (6 years ago) |
| Entity Number: | 5552964 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Principal Address: | 8000 MARINA BLVD., STE. 300, BRISBANE, CA, United States, 94005 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY STREET, NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| MORENO PERUGINI | Chief Executive Officer | 8000 MARINA BLVD., STE. 300, BRISBANE, CA, United States, 94005 |
| Name | Role | Address |
|---|---|---|
| C/O C T CORPORATION SYSTEM | DOS Process Agent | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-05-12 | 2025-05-12 | Address | 8000 MARINA BLVD., STE. 300, BRISBANE, CA, 94005, USA (Type of address: Chief Executive Officer) |
| 2025-05-12 | 2025-05-12 | Address | 1007 US HIGHWAY 202/206, BUILDING JR2, SUITE E102, BRIDGEWATER, NJ, 08807, USA (Type of address: Chief Executive Officer) |
| 2023-05-27 | 2025-05-12 | Address | 8000 MARINA BLVD., STE. 300, BRISBANE, CA, 94005, USA (Type of address: Chief Executive Officer) |
| 2023-05-27 | 2025-05-12 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| 2023-05-27 | 2023-05-27 | Address | 8000 MARINA BLVD., STE. 300, BRISBANE, CA, 94005, USA (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 250512001443 | 2025-05-12 | BIENNIAL STATEMENT | 2025-05-12 |
| 230527000446 | 2023-05-27 | BIENNIAL STATEMENT | 2023-05-01 |
| 210527060088 | 2021-05-27 | BIENNIAL STATEMENT | 2021-05-01 |
| 190515000285 | 2019-05-15 | APPLICATION OF AUTHORITY | 2019-05-15 |
This company hasn't received any reviews.
Date of last update: 23 Mar 2025
Sources: New York Secretary of State